Hu et al. clarified that mutant TP53 might play an important role in the progress of high-grade serous ovarian cancer by up-regulating the gene expression of key enzymes in fatty acid and cholesterol biosynthesis (Hu et al., 2013). The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.